Stopping long-term mepolizumab may lead to exacerbations, loss of asthma control
07 Oct 2020
byRoshini Claire Anthony
In patients with severe eosinophilic asthma, cessation of mepolizumab may lead to increased exacerbations and reductions in asthma control, according to results of the COMET* trial.
Stopping long-term mepolizumab may lead to exacerbations, loss of asthma control
07 Oct 2020